GB0812191D0 - Modified cells and methods of monitoring their viability - Google Patents

Modified cells and methods of monitoring their viability

Info

Publication number
GB0812191D0
GB0812191D0 GBGB0812191.5A GB0812191A GB0812191D0 GB 0812191 D0 GB0812191 D0 GB 0812191D0 GB 0812191 A GB0812191 A GB 0812191A GB 0812191 D0 GB0812191 D0 GB 0812191D0
Authority
GB
United Kingdom
Prior art keywords
viability
monitoring
methods
modified cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0812191.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greater Glasgow Health Board
Original Assignee
Greater Glasgow Health Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greater Glasgow Health Board filed Critical Greater Glasgow Health Board
Priority to GBGB0812191.5A priority Critical patent/GB0812191D0/en
Publication of GB0812191D0 publication Critical patent/GB0812191D0/en
Priority to GB0911486A priority patent/GB2461398A/en
Priority to PCT/GB2009/050781 priority patent/WO2010001175A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1896—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB0812191.5A 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability Ceased GB0812191D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0812191.5A GB0812191D0 (en) 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability
GB0911486A GB2461398A (en) 2008-07-03 2009-07-02 Globin MRI reporter genes
PCT/GB2009/050781 WO2010001175A1 (en) 2008-07-03 2009-07-02 Modified cells and methods of monitoring their viability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812191.5A GB0812191D0 (en) 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability

Publications (1)

Publication Number Publication Date
GB0812191D0 true GB0812191D0 (en) 2008-08-13

Family

ID=39717914

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0812191.5A Ceased GB0812191D0 (en) 2008-07-03 2008-07-03 Modified cells and methods of monitoring their viability
GB0911486A Withdrawn GB2461398A (en) 2008-07-03 2009-07-02 Globin MRI reporter genes

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0911486A Withdrawn GB2461398A (en) 2008-07-03 2009-07-02 Globin MRI reporter genes

Country Status (2)

Country Link
GB (2) GB0812191D0 (en)
WO (1) WO2010001175A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247501B2 (en) * 2000-06-22 2007-07-24 Henry Ford Health System Imaging and targeting tumors using sickle cells
ATE535260T1 (en) * 2001-06-29 2011-12-15 Sloan Kettering Inst Cancer VECTOR CODING HUMAN GLOBIN GENE AND ITS USE IN THE TREATMENT OF HEMOGLOBINOPATHIES
ES2327912T3 (en) * 2002-03-07 2009-11-05 Carnegie Mellon University CONTRACT AGENTS FOR THE FORMATION OF MAGNETIC RESONANCE IMAGES AND METHODS RELATED TO THEMSELVES.
DE60333487D1 (en) * 2002-12-13 2010-09-02 Genetix Pharmaceuticals Inc THERAPEUTIC RETROVIRUS VECTORS FOR GENE THERAPY
WO2005097208A2 (en) * 2004-03-26 2005-10-20 University Of Florida Research Foundation, Inc. Tissue oxygenation measurements
ATE519777T1 (en) * 2006-06-08 2011-08-15 Multi Magnetics Inc MAGNETOSOME GENE EXPRESSION IN EUKARYOTIC CELLS

Also Published As

Publication number Publication date
GB2461398A (en) 2010-01-06
WO2010001175A1 (en) 2010-01-07
GB0911486D0 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
IL272848B (en) Methods for reprogramming cells and uses thereof
PL3323883T3 (en) Defined cell culturing surfaces and methods of use
EP2376920A4 (en) Methods of detection of changes in cells
EG26164A (en) Electrolytic cell and method of use thereof
SG2014014484A (en) Electrolytic cell and method of use thereof
EP2181482A4 (en) Battery cell design and methods of its construction
EP2391711A4 (en) Novel cell lines and methods
EP2294406A4 (en) Methods and instrumentation for during-synthesis monitoring of polymer functional evolution
HK1138374A1 (en) Methods of evaluating cells and cell cultures
EP2299523A4 (en) Battery and method of manufacturing same
EP2279291A4 (en) Coferons and methods of making and using them
EP2401357A4 (en) Host cells and methods of use
EP2291513A4 (en) Hemangio colony forming cells and non-engrafting hemangio cells
EP2393930A4 (en) Cell lines expressing cftr and methods of using them
EP2246414A4 (en) Cell culture method and screening method
HK1152321A1 (en) Cell lines expressing gabaa and methods of using them
GB2460552B (en) Stem cell culture media and methods
SG10201405455UA (en) Cells and methods for obtaining them
EP2286479A4 (en) Battery parts and associated methods of manufacture and use
EP2277192A4 (en) Solar cells and method of making solar cells
GB0812789D0 (en) Materials and methods for cell growth
EP2553115A4 (en) Methods for culturing and analyzing cells
EP2391710A4 (en) Cell lines expressing guanylate cyclase-c and methods of using them
PL2318020T3 (en) Immunosuppressive blood cells and methods of producing same
GB0911486D0 (en) Modified cells and methods of monitoring their viability

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)